IFYcesom-LS
Description_Effects
IFYcesom-LS is a combination medication that contains Levosulpiride and Esomeprazole, used primarily for the treatment of gastroesophageal reflux disease (GERD), functional dyspepsia, and other acid-related digestive disorders. Levosulpiride is a prokinetic agent that enhances gastrointestinal motility by increasing the movement of the stomach and intestines. It works by blocking certain dopamine receptors in the gut and brain, helping to relieve symptoms like nausea, bloating, fullness, and delayed gastric emptying. Esomeprazole is a proton pump inhibitor (PPI) that significantly reduces the production of stomach acid by inhibiting the proton pumps in the stomach lining. This helps in healing acid-induced inflammation and ulcers and provides relief from heartburn, acidity, and indigestion. Together, these two components offer a dual benefit: Levosulpiride improves gastric motility and symptom control, while Esomeprazole provides acid suppression for healing and prevention of acid reflux damage. IFYcesom-LS is typically prescribed when conventional antacids or acid reducers alone are not sufficient. For best results, it should be taken as directed by your healthcare provider, usually before meals. Regular use along with dietary and lifestyle changes can enhance its effectiveness and long-term digestive health.
